NCT03982004 Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer Status TERMINATED Phase PHASE1
NCT03979014 Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative Treatment for Cervical Intra-epithelial Neoplasia Status COMPLETED Phase PHASE3
NCT03978689 A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma Status COMPLETED Phase PHASE1
NCT03978624 Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03976375 Efficacy and Safety of Pembrolizumab (MK-3475) With Lenvatinib (E7080/MK-7902) vs. Docetaxel in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease (PD) After Platinum Doublet Chemotherapy and Immunotherapy (MK-7902-008/E7080-G000-316/LEAP-008) Status COMPLETED Phase PHASE3
NCT03976362 A Study of Pembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC, MK-7339-008/KEYLYNK-008) Status COMPLETED Phase PHASE3
NCT03976323 Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006) Status COMPLETED Phase PHASE3
NCT03969901 Safety, Tolerability, Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in Pediatric Participants With Gram-negative Bacterial Infection (MK-7655A-021) Status COMPLETED Phase PHASE2/PHASE3
NCT03965130 The Effect of Glucagon on Rates of Hepatic Mitochondrial Oxidation in Man Assessed by PINTA Status COMPLETED Phase PHASE1
NCT03954067 A Study of an Intratumoral Oncolytic Virus in Patients With Advanced Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT03950856 Lot-to-Lot Consistency of V114 in Healthy Adults (V114-020) Status COMPLETED Phase PHASE3
NCT03950674 Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189)-Japan Extension Study Status COMPLETED Phase PHASE3
NCT03950622 Safety and Immunogenicity of V114 in Healthy Adults (V114-019/PNEU-AGE) Status COMPLETED Phase PHASE3
NCT03948763 A Study of mRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001) Status TERMINATED Phase PHASE1
NCT03947775 HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL Status NOT_YET_RECRUITING Phase PHASE2